TY  - GEN
AU  - Akuffo,Emma L
AU  - Davis,John B
AU  - Fox,Steven M
AU  - Gloger,Israel S
AU  - Hosford,David
AU  - Kinsey,Emma E
AU  - Jones,Neil A
AU  - Nock,Christina M
AU  - Roses,Allen D
AU  - Saunders,Ann M
AU  - Skehel,J Mark
AU  - Smith,Marjorie A
AU  - Cutler,Paul
TI  - The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone
SN  - 1354-750X
PY  - 2008///1202
KW  - Aged
KW  - Alzheimer Disease
KW  - drug therapy
KW  - Apolipoproteins E
KW  - blood
KW  - Biomarkers
KW  - Cognition
KW  - drug effects
KW  - Complement C1 Inactivator Proteins
KW  - metabolism
KW  - Complement C1 Inhibitor Protein
KW  - Complement Factor H
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Europe
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - New Zealand
KW  - Nootropic Agents
KW  - therapeutic use
KW  - Proteomics
KW  - Reproducibility of Results
KW  - Rosiglitazone
KW  - Severity of Illness Index
KW  - Thiazolidinediones
KW  - Time Factors
KW  - Treatment Outcome
KW  - alpha-Macroglobulins
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1080/13547500802445199
ER  -